Possibia

136942

Last Update Posted: 2021-02-18

Recruiting has ended

All Genders

accepted

18 Years-80 Years

370 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol

The proportion of patients achieving LDL-C target as defined by Swiss cholesterol recommendations (AGLA-recommendations) across starting doses of 10 mg, 20 mg, 40 mg, and 80 mg of atorvastatin.

Eligibility

Relevant conditions:

Hyperlipidemia

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov